Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
We describe 11 patients with massive brain infection with viable cysticerci, undetectable inflammatory reaction on CNS imaging, and an unexpectedly high (82%) prevalence of tapeworm infection. With the exception of two individuals with heavy parasite loads, patients had a relatively benign clinical course and tolerated the use of cysticidal drugs. This group of patients represents a particular presentation of neurocysticercosis, different from the previously described syndromes of cysticercotic encephalitis and disseminated systemic cysticercosis.
García
H H
HH
Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Perú. hgarcia@pol.com.pe
Del Brutto
O H
OH
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D001927:Brain Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology*; D002353:Carrier State; D002648:Child; D003551:Cysticercosis / Q000150:complications / Q000453:epidemiology; D003552:Cysticercus / Q000302:isolation & purification; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020019:Neurocysticercosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology*; D011223:Praziquantel / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000871:Anthelmintics; D011223:Praziquantel; D015766:Albendazole